GlassScriptPhysician profile
William Arthur Jackson
NPI 1760471130
$25,418.33
in general payments reported to CMS, 2019-2025
43 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $1,044 · 2021: $1,244 · 2022: $1,271 · 2023: $1,460 · 2024: $1,525 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,014.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17,846.41 | 2019-2024 | Xarelto |
| Biotronik INC. | $1,134.62 | 2019-2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Novartis Pharmaceuticals Corporation | $860.89 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $466.76 | 2019-2024 | Lifevest |
| Pfizer INC. | $425.73 | 2019-2025 | |
| Amgen INC. | $422.41 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $412.85 | 2021-2025 | Verquvo, Capvaxive |
| Philips North America LLC | $349.63 | 2023-2024 | (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Boston Scientific Corporation | $304.56 | 2019-2024 | Watchman Access System, Watchman Flx, Wavewriter Alpha Prime 16 |
| Amarin Pharma, INC. | $302.68 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $247.22 | 2019-2024 | Eliquis |
| Sanofi-Aventis U.S. LLC | $228.93 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $220.78 | 2019-2021 | |
| Vital Connect, INC | $208.66 | 2023-2024 | Vitalpatch Rtm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.22 | 2019-2024 | Jardiance |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $195.83 | 2025 | Sapien 3 Ultra Resilia |
| Astellas Pharma US INC | $125.73 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $118.09 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Novo Nordisk INC | $114.37 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $90.48 | 2019-2023 | Farxiga |
| Cvrx, INC. | $90.07 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $90.01 | 2019-2024 | Esprit |
| Medtronic, INC. | $86.84 | 2022-2025 | Cobalt Dr Mri Surescan |
| Shockwave Medical, INC | $79.95 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals International, Plc | $79.82 | 2024 | Arcalyst |
| Atricure, INC. | $74.98 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $71.19 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Biosense Webster, INC. | $63.10 | 2021 | |
| Irhythm Technologies, INC. | $57.17 | 2022-2023 | Zio Xt Patch |
| Innovation Technologies INC | $50.47 | 2024 | Irrisept |
| Daiichi Sankyo INC. | $42.16 | 2025 | Injectafer |
| Alnylam Pharmaceuticals INC. | $41.66 | 2022-2024 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $40.25 | 2023 | Arcalyst |
| Stryker Corporation | $38.30 | 2025 | Artix Mt |
| Organogenesis INC. | $36.98 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.40 | 2025 | |
| Angiodynamics, INC. | $31.13 | 2025 | Auryon Laser System 100-120 Vac |
| Regeneron Healthcare Solutions, INC. | $25.60 | 2024 | Evkeeza, Praluent |
| Kerecis Limited | $25.26 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medicomp INC | $24.32 | 2023 | Telepatch Cardiac Monitor |
| Vivaquant INC, Dba Rhythm Express | $22.32 | 2024 | Rhythm Express |
| Baxter Healthcare | $19.90 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Inspire Medical Systems, INC. | $13.60 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.